U.S. Microbial Fermentation Technology Market Size, Share & Trends Analysis Report By Application (Antibiotics, Probiotics Supplements), By End-user (Biopharmaceutical Companies, Contract Research Organizations), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Application
                        1.2.2. End-user
                        1.2.3. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Application Outlook
                        2.2.2. End-user Outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Microbial Fermentation Technology Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                        3.2.3. Market opportunity analysis
                    3.3. U.S. Microbial Fermentation Technology Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
Chapter 4. U.S. Microbial Fermentation Technology Market: Application Estimates & Trend Analysis
                    4.1. U.S. Microbial Fermentation Technology Market: Application Dashboard
                    4.2. U.S. Microbial Fermentation Technology Market: Application Movement Analysis
                    4.3. U.S. Microbial Fermentation Technology Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    4.4. Antibiotics
                        4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.5. Probiotics Supplements
                        4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.6. Monoclonal Antibodies
                        4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.7. Recombinant Proteins
                        4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.8. Biosimilars
                        4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.9. Vaccines
                        4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.10. Enzymes
                        4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.11. Small Molecules
                        4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.12. Other Applications
                        4.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Microbial Fermentation Technology Market: End-user Estimates & Trend Analysis
                    5.1. U.S. Microbial Fermentation Technology Market: End-user Dashboard
                    5.2. U.S. Microbial Fermentation Technology Market: End-user Movement Analysis
                    5.3. U.S. Microbial Fermentation Technology Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                    5.4. Biopharmaceutical Companies
                        5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.5. Contract Research Organizations
                        5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.6. CMOs & CDMOs
                        5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.7. Academic & Research Organizations
                        5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
                    6.1. Recent Developments & Impact Analysis, By Key Market Participants
                    6.2. Company/Competition Categorization
                    6.3. Vendor Landscape
                        6.3.1. List of key distributors and channel partners
                        6.3.2. Key customers
                        6.3.3. Key company market share analysis, 2023
                        6.3.4. Biocon Ltd.
                            6.3.4.1. Company overview
                            6.3.4.2. Financial performance
                            6.3.4.3. Product benchmarking
                            6.3.4.4. Strategic initiatives
                        6.3.5. BioVectra Inc.
                            6.3.5.1. Company overview
                            6.3.5.2. Financial performance
                            6.3.5.3. Product benchmarking
                            6.3.5.4. Strategic initiatives
                        6.3.6. Danone
                            6.3.6.1. Company overview
                            6.3.6.2. Financial performance
                            6.3.6.3. Product benchmarking
                            6.3.6.4. Strategic initiatives
                        6.3.7. F. Hoffmann-La Roche AG
                            6.3.7.1. Company overview
                            6.3.7.2. Financial performance
                            6.3.7.3. Product benchmarking
                            6.3.7.4. Strategic initiatives
                        6.3.8. Koninklijke DSM NV
                            6.3.8.1. Company overview
                            6.3.8.2. Financial performance
                            6.3.8.3. Product benchmarking
                            6.3.8.4. Strategic initiatives
                        6.3.9. Lonza
                            6.3.9.1. Company overview
                            6.3.9.2. Financial performance
                            6.3.9.3. Product benchmarking
                            6.3.9.4. Strategic initiatives
                        6.3.10. Novozymes A/S
                            6.3.10.1. Company overview
                            6.3.10.2. Financial performance
                            6.3.10.3. Product benchmarking
                            6.3.10.4. Strategic initiatives
                        6.3.11. TerraVia Holdings, Inc. (Corbion)
                            6.3.11.1. Company overview
                            6.3.11.2. Financial performance
                            6.3.11.3. Product benchmarking
                            6.3.11.4. Strategic initiatives
                        6.3.12. BIOZEEN
                            6.3.12.1. Company overview
                            6.3.12.2. Financial performance
                            6.3.12.3. Product benchmarking
                            6.3.12.4. Strategic initiatives
                        6.3.13. Biovian Oy
                            6.3.13.1. Company overview
                            6.3.13.2. Financial performance
                            6.3.13.3. Product benchmarking
                            6.3.13.4. Strategic initiatives

List of Tables

Table 1. List of abbreviation
Table 2. U.S. microbial fermentation technology market, 2018 - 2030 (USD Million)
Table 3. U.S. microbial fermentation technology market, by application, 2018 - 2030 (USD Million)
Table 4. U.S. microbial fermentation technology market, by end-user, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. microbial fermentation technology market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Product and stage segment snapshot
Fig. 11 Sales channel segment snapshot
Fig. 12 Market dynamics
Fig. 13 Porter’s five forces analysis
Fig. 14 PESTLE analysis
Fig. 15 U.S. microbial fermentation technology market: Application outlook and key takeaways
Fig. 16 U.S. microbial fermentation technology market: Application movement analysis
Fig. 17 Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Probiotics supplements market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Monoclonal antibodies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Recombinant proteins market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Biosimilars market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Vaccines market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Small molecules market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 U.S. microbial fermentation technology market: End-user outlook and key takeaways
Fig. 27 U.S. microbial fermentation technology market: End-user movement analysis
Fig. 28 Biopharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Contract research organizations market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 CMOs & CDMOs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Academic & research organizations market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Company market share analysis, 2023
Fig. 33 Strategic framework